IRB-Brasil Resseguros S.A. (IRBR3.SA)
Rio de Janeiro, RJ, BR
Operating both domestically within Brazil and across international territories, IRB-Brasil Resseguros S.A. delivers comprehensive reinsurance services. Its extensive portfolio encompasses a broad spectrum of risks, offering specialized coverage for areas such as aviation, engineering projects, civil liabilities, surety bonds, rural activities, financial exposures, oil and gas ventures, property, general casualty events, agricultural operations, cargo and marine transport, and life and pension plans, among a host of other diverse segments. Founded in 1939, its corporate headquarters are situated in Rio de Janeiro, Brazil.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.77% | -0.26% | -6.04% | -12.11% | +1.69% | +0.95% | +16.12% | +47.12% | -66.50% | -76.46% | -76.46% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 2 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Reinsurance: +19.7%-1,206.8% Q1'26: -41.8% (vs Q1'25)
-
EPS growth Insurance - Reinsurance: +47.7%-51.5% Q1'26: -29.9% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Reinsurance: +7.0%+43.3% ★ Q1'26: +24.3% (vs Q1'25)
-
EBIT margin Insurance - Reinsurance: +13.4%+48.7% ★ Q1'26: +54.1% (vs Q1'25)
-
ROIC Insurance - Reinsurance: +4.0%+87.7% ★ Q1'26: +66.6% (vs Q1'25)
-
Share dilution Insurance - Reinsurance: +0.2%0.0% Q1'26: -0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Reinsurance: 0.00×0.40× ★ Q1'26: 0.42× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 4 Rev. Ana. 5 EPS Ana. |
Dec 2028 3 Rev. Ana. 4 EPS Ana. |
Dec 2029 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.93B
est: 5.05B (-22.3%)
|
4.97B
est: 6.03B (-17.5%)
|
6.01B
est: 7.28B (-17.5%)
|
5.62B
est: 7.76B (-27.7%)
|
6.33B
est: 6.56B (-3.5%)
|
-1.35B
est: 6.25B (-121.7%)
|
-581.28M
est: 6.44B (-109.0%)
|
-111.88M
est: 4.86B (-102.3%)
|
1.24B
est: 4.19B (-70.4%)
|
4.58B
4.44B – 4.73B
+9.4% YoY
|
4.94B
4.61B – 5.26B
+7.8% YoY
|
4.66B
4.55B – 4.78B
-5.6% YoY
|
7.31B
6.94B – 7.66B
+56.7% YoY
|
| EBITDA |
2.42B
est: -986.09M (+345.3%)
|
2.06B
est: -1.18B (+274.7%)
|
1.23B
est: -1.42B (+186.5%)
|
-758.49M
est: -1.52B (+49.9%)
|
-484.81M
est: -1.28B (+62.1%)
|
-533.03M
est: -1.22B (+56.3%)
|
91.88M
est: -367.53M (+125.0%)
|
2.67B
est: -277.40M (+1,062.3%)
|
687.63M
est: -239.26M (+387.4%)
|
-261.77M
-270.07M – -253.47M
-9.4% YoY
|
-282.22M
-300.13M – -263.14M
-7.8% YoY
|
-266.40M
-273.02M – -259.79M
+5.6% YoY
|
-417.54M
-437.70M – -396.49M
-56.7% YoY
|
| EBIT |
2.38B
est: -864.24M (+375.3%)
|
2.01B
est: -1.03B (+294.4%)
|
1.18B
est: -1.25B (+195.1%)
|
-805.86M
est: -1.33B (+39.3%)
|
-529.18M
est: -1.12B (+52.8%)
|
-582.55M
est: -1.07B (+45.5%)
|
34.08M
est: -289.90M (+111.8%)
|
2.57B
est: -218.81M (+1,276.2%)
|
602.56M
est: -188.72M (+419.3%)
|
-206.47M
-213.02M – -199.92M
-9.4% YoY
|
-222.60M
-236.73M – -207.56M
-7.8% YoY
|
-210.13M
-215.34M – -204.91M
+5.6% YoY
|
-329.34M
-345.24M – -312.74M
-56.7% YoY
|
| Net Income |
925.05M
est: 2.25B (-58.8%)
|
1.22B
est: 2.91B (-58.2%)
|
1.21B
est: 4.04B (-70.0%)
|
-1.48B
est: -1.93B (+23.3%)
|
-682.70M
est: -625.63M (-9.1%)
|
-420.74M
est: -841.31M (+50.0%)
|
-123.85M
est: 368.93M (-133.6%)
|
805.74M
est: 361.71M (+122.8%)
|
390.95M
est: 495.31M (-21.1%)
|
582.88M
553.35M – 612.41M
+17.7% YoY
|
681.95M
669.11M – 698.03M
+17.0% YoY
|
769.69M
738.12M – 829.15M
+12.9% YoY
|
797.72M
745.43M – 847.79M
+3.6% YoY
|
| SGA |
277.16M
est: -284.44M (+197.4%)
|
155.23M
est: -339.53M (+145.7%)
|
128.60M
est: -410.08M (+131.4%)
|
89.22M
est: -437.13M (+120.4%)
|
106.18M
est: -369.28M (+128.8%)
|
11.01M
est: -351.95M (+103.1%)
|
31.37M
est: -355.93M (+108.8%)
|
28.20M
est: -268.64M (+110.5%)
|
25.82M
est: -231.70M (+111.1%)
|
-253.50M
-261.55M – -245.46M
-9.4% YoY
|
-273.30M
-290.65M – -254.83M
-7.8% YoY
|
-257.99M
-264.40M – -251.59M
+5.6% YoY
|
-404.36M
-423.88M – -383.97M
-56.7% YoY
|
| EPS |
27.54
est: 27.44 (+0.4%)
|
36.28
est: 35.61 (+1.9%)
|
36.03
est: 49.34 (-27.0%)
|
-30.17
est: -23.60 (-27.9%)
|
-13.54
est: -7.64 (-77.1%)
|
-15.06
est: -9.89 (-52.3%)
|
-1.51
est: 4.51 (-133.5%)
|
9.85
est: 4.43 (+122.5%)
|
4.78
est: 6.11 (-21.8%)
|
7.24
6.76 – 7.49
+18.4% YoY
|
8.40
8.18 – 8.53
+16.1% YoY
|
9.52
9.02 – 10.13
+13.4% YoY
|
9.75
9.11 – 10.36
+2.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 2/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 2/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 2/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 2/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 1/5 | 2/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-15 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Antonio Cassio dos Santos | Member of Executive Board & Independent Director | — | male |
| Bernardo Netto Arruda | General Counsel & Legal Claims Director | — | male |
| Daniel Volpe | Retrocession & Technical Director | — | male |
| Debora Tavares | Director of Internal Controls, Risks & Compliance | — | — |
| Eduarda Cunha de La Rocque | Director of Internal Controls, Risks & Compliance | — | female |
| Frederico Knapp | Chief Financial Officer | — | male |
| Hugo Daniel Castillo Irigoyen | Chief Reinsurance Officer | — | male |
| Luciana Martos | Director of People | — | — |
| Marcos Pessoa de Queiroz Falcao | Chief Executive Officer & Investor Relations Officer | — | male |
| Thays Vargas Ferreira | Control & Finance Director | — | female |
| Wilson Toneto | Member of the Executive Board & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IRBR3.SA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
